Top Therapeutics Companies
203 Therapeutics companies, sorted by total funding raised.
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
Developing inhaled therapies to treat people with severe respiratory disease.
Clinical-stage oncology company developing novel CAR-T cell therapies for hematological malignanc...
Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.
Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...
Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for ...
Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...
Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...
Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...
Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...
A clinical-stage biopharma company based in Lyon, France
Clinical-stage immunology biotech using machine learning to design biologic therapeutics for auto...
Commercial-stage biopharmaceutical company developing therapies for rare hematologic diseases by ...
Developing novel optogenetic gene therapies for patients with blinding diseases.
Gene therapy company developing precision gene therapies for debilitating neurological disorders,...
A clinical-stage pharmaceutical company with the aspiration of becoming a leader in neuroscience.
Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...
An innovative gene therapy company with a proprietary platform for rationally designed adeno-asso...
Biotech company developing engineered cell therapies using satellite cells for liver and other or...
Biotechnology company developing next-generation genetic medicines using a proprietary protein na...
Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe...
Clinical-stage biotechnology company developing T cell receptor (TCR)-engineered T cell therapies...
Mirum Pharmaceuticals, Inc. is a clinical-stage therapeutics company developing a novel approach ...
Callio Therapeutics is developing next‐generation dual‐payload antibody drug conjugates (ADCs) fo...
Develops next-generation engineered T-cell therapies (CAR-T and TCR) for oncology, partnering wit...